Dr. David S. Hanson
Claim this profileMary Bird Perkins Cancer Center
About David S. Hanson
Education:
- Obtained an MD from the University of Colorado School of Medicine, 1985.
- Graduated summa cum laude with an undergraduate degree in Biological Science from the University of Denver.
Experience:
- Possesses over 37 years of experience in Hematology & Oncology.
- Board-certified in Medical Oncology and Internal Medicine.
- Completed internship, residency, and fellowship in Hematology and Oncology at the University of Colorado Health Science Center.
- Serves as a Senior Consultant of Hematology and Oncology services at the Mayo Clinic in Jacksonville, Florida, since 1994.
- Currently practicing at Mary Bird Perkins Cancer Center in Baton Rouge, LA.
Area of expertise
Lung Cancer
David S. Hanson has run 11 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
David S. Hanson has run 8 trials for Breast Cancer. Some of their research focus areas include:
Affiliated Hospitals
Mary Bird Perkins Cancer Center
Louisiana Hematology Oncology Associates LLC
Clinical Trials David S. Hanson is currently running
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Gemcitabine + Cisplatin
for Bladder Cancer
This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Recruiting
1 award
Phase 2
More about David S. Hanson
Clinical Trial Related
6 years of experience running clinical trials · Led 38 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments David S. Hanson has experience with
- Nivolumab
- Cisplatin
- Atezolizumab
- Paclitaxel
- Ipilimumab
- Carboplatin
Breakdown of trials David S. Hanson has run
Lung Cancer
Breast Cancer
Breast cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David S. Hanson specialize in?
David S. Hanson focuses on Lung Cancer and Breast Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage II.
Is David S. Hanson currently recruiting for clinical trials?
Yes, David S. Hanson is currently recruiting for 5 clinical trials in Baton Rouge Louisiana. If you're interested in participating, you should apply.
Are there any treatments that David S. Hanson has studied deeply?
Yes, David S. Hanson has studied treatments such as Nivolumab, Cisplatin, Atezolizumab.
What is the best way to schedule an appointment with David S. Hanson?
Apply for one of the trials that David S. Hanson is conducting.
What is the office address of David S. Hanson?
The office of David S. Hanson is located at: Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana 70809 United States. This is the address for their practice at the Mary Bird Perkins Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.